IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 239 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,293,670 | -54.1% | 2,482,125 | -29.0% | 0.00% | -50.0% |
Q2 2023 | $24,623,160 | -47.6% | 3,497,608 | -54.5% | 0.00% | -60.0% |
Q1 2023 | $47,002,342 | +48.0% | 7,692,691 | +54.8% | 0.01% | +25.0% |
Q4 2022 | $31,757,462 | +216.3% | 4,969,869 | +374.2% | 0.00% | +300.0% |
Q3 2022 | $10,040,000 | -37.3% | 1,048,000 | -27.7% | 0.00% | -50.0% |
Q2 2022 | $16,008,000 | +72.1% | 1,450,057 | +159.5% | 0.00% | +100.0% |
Q1 2022 | $9,302,000 | +92.2% | 558,750 | +120.3% | 0.00% | 0.0% |
Q4 2021 | $4,841,000 | -38.4% | 253,575 | -20.5% | 0.00% | 0.0% |
Q3 2021 | $7,863,000 | +26.1% | 318,859 | +33.1% | 0.00% | 0.0% |
Q2 2021 | $6,235,000 | -64.4% | 239,597 | -56.7% | 0.00% | -66.7% |
Q1 2021 | $17,517,000 | +99.0% | 553,314 | +191.8% | 0.00% | +200.0% |
Q4 2020 | $8,801,000 | +146.9% | 189,653 | +75.1% | 0.00% | 0.0% |
Q3 2020 | $3,565,000 | -15.7% | 108,285 | -29.7% | 0.00% | 0.0% |
Q2 2020 | $4,227,000 | +40.0% | 153,982 | +52.7% | 0.00% | 0.0% |
Q1 2020 | $3,020,000 | -42.3% | 100,858 | -46.6% | 0.00% | 0.0% |
Q4 2019 | $5,230,000 | -2.1% | 188,930 | -35.6% | 0.00% | 0.0% |
Q3 2019 | $5,344,000 | +484.0% | 293,567 | +686.7% | 0.00% | – |
Q2 2019 | $915,000 | +5.2% | 37,318 | -59.2% | 0.00% | – |
Q1 2019 | $870,000 | -56.3% | 91,508 | -59.3% | 0.00% | -100.0% |
Q4 2018 | $1,990,000 | +17.9% | 224,873 | +49.8% | 0.00% | – |
Q3 2018 | $1,688,000 | -50.8% | 150,092 | -44.0% | 0.00% | -100.0% |
Q2 2018 | $3,430,000 | +26.9% | 267,955 | +67.5% | 0.00% | 0.0% |
Q1 2018 | $2,703,000 | +166.8% | 159,959 | +26.3% | 0.00% | – |
Q4 2017 | $1,013,000 | +52.1% | 126,682 | +47.5% | 0.00% | – |
Q3 2017 | $666,000 | +78.6% | 85,875 | +69.4% | 0.00% | – |
Q2 2017 | $373,000 | – | 50,702 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |